ASN Kidney Week 2019
The oral hypoxia-inducible factor prolyl hydroxylase (HIF-PHI), roxadustat, is in last-stage development for the ...
In the OLYMPUS trial, researchers examined the efficacy of roxadustat for the treatment of anemia in patients with ...
Researchers, led by Ajay Sharma, conducted a study designed to develop and validate a predictive model to identify ...
Worldwide, the prevalence of chronic kidney disease (CKD) is on the rise. In the United States, approximately 15% of the ...
Washington, DC—Patients with gastroesophageal reflux disease and peptic ulcer disease are commonly treated with proton ...
Hyperkalemia, an electrolyte abnormality, is common in patients with chronic kidney disease (CKD). Treatment for ...
Patiromer, a sodium-free potassium binder approved for treating hyperkalemia in adults is not currently approved for use ...
Increased excretion of urinary oxalate, enteric hyperoxaluria, can occur as a complication of fat malabsorption ...
Washington, DC—Canagliflozin is US FDA approved for treatment of patients with type 2 diabetes and estimated ...
Washington, DC—Patients with chronic kidney disease (CKD) who develop anemia may have reduced quality of life and ...
Washington, DC—One of the earliest indicators of kidney disease is new-onset albuminuria, which is predicted by an ...
Washington, DC—There is no association between the distance between a patient’s residence and a kidney transplant ...
Washington, DC—The treatment of choice for patients with end-stage renal disease is kidney transplantation, and living ...
Patients with chronic kidney disease (CKD) who develop metabolic acidosis are at risk for accelerated decline in ...
Washington, DC—Varying definitions of chronic kidney disease (CKD) and diagnosis accuracy in medical records ...
Tolvaptan is approved for the treatment of adult patients with autosomal dominant polycystic kidney disease (ADPKD).
Patients with autosomal dominant polycystic kidney disease (ADPKD) at highest risk for disease progression
The American College of Cardiology/American Heart Association (ACC/AHA) issued new hypertension guidelines in 2017 that ...
Results of studies have suggested that chronic kidney disease (CKD) is an independent predictor of stroke; the studies ...
Renal pathology is critical in clinical management and prognosis in patients with immunoglobulin A nephropathy (IgAN)
Despite hemodialysis, patients with end-stage renal disease frequently experience predialysis hyperkalemia.
There is no clear consensus on the optimal timing of initiation of dialysis in critically ill patients with acute kidney ...
Researchers, led by Patrick H. Pun, MD, conducted a retrospective analysis to evaluate trends and the use and ...
Increased morbidity and mortality are both associated with acute kidney injury in critically ill patients.
Hyperkalemia resulting from kidney failure is associated with life-threatening arrhythmias. Joshua Powell, MD, and ...
The HIMALYAYAS trial was a phase 3 study of the efficacy and safety of roxadustat in the treatment of anemia in incident ...
Washington, DC—Outcomes following kidney transplantation may be predicted by measures of functional and nutrition ...
Washington, DC—Researchers, led by Matthew Weir, MD, conducted a post hoc analysis to examine the efficacy and ...
For patients with chronic kidney disease (CKD), multidisciplinary education can play a role in prevention of disease ...
In children with celiac disease, the protein zonulin increased gut permeability after exposure to gliadin. In children ...
Previous studies in patients with lupus nephritis have shown impairment in both the number and function of T-regulatory ...
For patients with end-stage renal disease (ESRD), the optimal choice for renal replacement therapy is renal transplant. ...
There are few data available on estimated glomerular filtration rate (eGFR) decline in patients with chronic kidney ...
Patients with end-stage renal disease require close monitoring of nutrition. However, in patients on hemodialysis, ...
There is an association between hyperkalemia and adverse clinical events in patients on hemodialysis identified by a ...
Despite the importance of body composition in the prognosis of dialysis patients, there are few data available on ...
UP to 44% of patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT) experience ...
Reactions to a diagnosis of autosomal dominant tubule-interstitial kidney disease (ADTKD) due to UMOD and MUC1 mutations ...
The impact of influenza virus, particularly A(H1N1) is associated with high risk of mortality in patients who develop ...
Standard treatment for critically ill patients with acute kidney injury (AKI) is continuous renal replacement therapy ...
Washington, DC—The treatment of choice for patients with end-stage renal disease is kidney transplantation, and living ...
Patients in the intensive care unit (ICU) who develop acute kidney injury (AKI) are at increased risk of mortality. It ...
Patients with acute kidney injury (AKI) are at increased risk for chronic kidney disease, end-stage renal disease, and ...
Advertisement
Advertisement
